AAAAAA

   
Results: 1-3 |
Results: 3
Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma
Authors: Dring, AM Davies, FE Rollinson, SJ Roddam, PL Rawstron, AC Child, JA Jack, AS Morgan, GJ
Citation: Am. Dring et al., Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma, BR J HAEM, 112(1), 2001, pp. 249-250
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
Authors: Davies, FE Rollinson, SJ Rawstron, AC Roman, E Richards, S Drayson, M Child, JA Morgan, GJ
Citation: Fe. Davies et al., High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment, J CL ONCOL, 18(15), 2000, pp. 2843-2851
The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment
Authors: Rawstron, AC Rollinson, SJ Richards, S Short, MA English, A Morgan, GJ Hale, G Hillmen, P
Citation: Ac. Rawstron et al., The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment, BR J HAEM, 107(1), 1999, pp. 148-153
Risultati: 1-3 |